The changing landscape of scientific communication at EASD Chantal MathieuEleanor KennedyHindrik Mulder Editorial 16 December 2022 Pages: 413 - 414
Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies Stephen R. KarpenJessica L. Dunneon behalf of the Type 1 Diabetes Consortium Review 22 July 2022 Pages: 415 - 424
Cardiovascular outcomes in type 1 and type 2 diabetes Annika RosengrenPigi Dikaiou Review Open access 14 January 2023 Pages: 425 - 437
Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register Minna HarsunenJarno L. T. KettunenTiinamaija Tuomi Article Open access 23 November 2022 Pages: 438 - 449
Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes Alexandra Coomans de BrachèneCorentin ScoubeauDecio L. Eizirik Article 19 November 2022 Pages: 450 - 460
Timing of physical activity in relation to liver fat content and insulin resistance Jeroen H. P. M. van der VeldeSebastiaan C. BooneRenée de Mutsert Article Open access 01 November 2022 Pages: 461 - 471
Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study Banafsheh ArshiJinluan ChenMaryam Kavousi Article Open access 08 November 2022 Pages: 472 - 481
Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort Elisa Dal CantoPetra J. M. EldersJoline W. J. Beulens Article Open access 08 November 2022 Pages: 482 - 494
High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease Hyunkyung KimKenneth E. WestermanMiriam S. Udler Article 20 December 2022 Pages: 495 - 507
The effect of age on longitudinal measures of beta cell function and insulin sensitivity during the progression of early stage type 1 diabetes Ele FerranniniAndrea MariCarmella Evans-Molina Article Open access 02 December 2022 Pages: 508 - 519
Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering Sejal MistryRamkiran GouripeddiJulio C. Facelli Article 30 November 2022 Pages: 520 - 534
Pancreatic alpha cell glucagon–liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes Xiaona CuiJin FengTianpei Hong Article Open access 04 November 2022 Pages: 535 - 550
Gene expression profiling in NOD mice reveals that B cells are highly educated by the pancreatic environment during autoimmune diabetes Joanne BoldisonJessica R. HopkinsonF. Susan Wong Article Open access 12 December 2022 Pages: 551 - 566
Distinct subcellular localisation of intramyocellular lipids and reduced PKCε/PKCθ activity preserve muscle insulin sensitivity in exercise-trained mice Rafael C. GasparKun LyuGerald I. Shulman Article 01 December 2022 Pages: 567 - 578
Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy Haifa MaalmiAlexander Stromthe GDS Group Article Open access 06 December 2022 Pages: 579 - 589
CCR2-positive monocytes contribute to the pathogenesis of early diabetic retinopathy in mice Aicha SaadaneAlexander A. VeenstraTimothy S. Kern Article Open access 26 January 2023 Pages: 590 - 602
Utility of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies: a viewpoint from the FDA Justin PenzenstadlerJustin C. EarpKristen Pluchino Letter 21 December 2022 Pages: 603 - 604
GLP1RAs vs SGLT2is were associated with lower risk of major adverse limb events and similar risks of heart failure hospitalisation and stroke? Lixin DuPan WangJianlan Ma Letter 18 November 2022 Pages: 605 - 606